123 related articles for article (PubMed ID: 6685483)
1. QSAR studies on psychotomimetic phenylalkylamines.
Gupta SP; Handa A; Bindal MC; Singh P
Arzneimittelforschung; 1983; 33(8):1089-90. PubMed ID: 6685483
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in psychotomimetic phenylalkylamines.
Aldous FA; Barrass BC; Brewster K; Buxton DA; Green DM; Pinder RM; Rich P; Skeels M; Tutt KJ
J Med Chem; 1974 Oct; 17(10):1100-11. PubMed ID: 4418757
[No Abstract] [Full Text] [Related]
3. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.
Glennon RA; Rosecrans JA; Young R
Med Res Rev; 1983; 3(3):289-340. PubMed ID: 6350763
[No Abstract] [Full Text] [Related]
4. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
Sanders-Bush E; Burris KD; Knoth K
J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
[TBL] [Abstract][Full Text] [Related]
5. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
[TBL] [Abstract][Full Text] [Related]
6. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
Titeler M; Lyon RA; Glennon RA
Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
[TBL] [Abstract][Full Text] [Related]
7. Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.
Nichols DE
J Theor Biol; 1976 Jun; 59(1):167-77. PubMed ID: 7711
[No Abstract] [Full Text] [Related]
8. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
9. A characteristic effect of hallucinogens on investigatory responding in rats.
Geyer MA; Light RK; Rose GJ; Petersen LR; Horwitt DD; Adams LM; Hawkins RL
Psychopharmacology (Berl); 1979 Sep; 65(1):35-40. PubMed ID: 116288
[TBL] [Abstract][Full Text] [Related]
10. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
Harvey JA; Gormezano I; Cool VA
J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
[No Abstract] [Full Text] [Related]
11. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
[TBL] [Abstract][Full Text] [Related]
12. Neurological aspects of hallucinogenic drugs.
Logan WJ
Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
[No Abstract] [Full Text] [Related]
13. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
Nichols DE; Pfister WR; Yim GK
Life Sci; 1978 Jun; 22(24):2165-70. PubMed ID: 672453
[No Abstract] [Full Text] [Related]
14. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
[TBL] [Abstract][Full Text] [Related]
15. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
[TBL] [Abstract][Full Text] [Related]
16. [A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].
Otaka T
Seishin Shinkeigaku Zasshi; 1974; 76(2):103-28. PubMed ID: 4472773
[No Abstract] [Full Text] [Related]
17. Monomethylthio analogues of 1-(2,4,5-trimethoxyphenyl)-2-aminopropane.
Jacob P; Anderson G; Meshul CK; Shulgin AT; Castagnoli N
J Med Chem; 1977 Oct; 20(10):1235-9. PubMed ID: 903913
[TBL] [Abstract][Full Text] [Related]
18. MDA and DOM: substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat.
Shannon HE
Psychopharmacology (Berl); 1980; 67(3):311-2. PubMed ID: 6770411
[TBL] [Abstract][Full Text] [Related]
19. Effect of a chiral 4-alkyl substituent in hallucinogenic amphetamines.
Oberlender R; Ramachandran PV; Johnson MP; Huang X; Nichols DE
J Med Chem; 1995 Sep; 38(18):3593-601. PubMed ID: 7658446
[TBL] [Abstract][Full Text] [Related]
20. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.
Pierce PA; Peroutka SJ
Psychopharmacology (Berl); 1989; 97(1):118-22. PubMed ID: 2540505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
